CREATIVE MEDICAL TECHNOLOGY (CELZ)
US22529Y4089 - Common Stock
CREATIVE MEDICAL TECHNOLOGY
NASDAQ:CELZ (4/25/2024, 7:00:00 PM)
4.4
-0.41 (-8.52%)
Company Profile
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm is focused on the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction, respectively. The CaverStem and FemCelz kits are available through physicians at eight locations in the United States. Its products include StemSpine, ImmCelz, and OvaStem. StemSpine is a regenerative stem cell procedure for the treatment of degenerative disc disease. ImmCelz is a universal donor stem cell therapy for stroke treatment. OvaStem is a stem cell therapy for premature ovarian failure.
Company Info
CREATIVE MEDICAL TECHNOLOGY
211 E. Osborn Rd.
Phoenix ARIZONA
P: 14803992822
Employees: 0
CELZ News
a month ago - Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings Provides Corporate Update
2 months ago - AB NewswireMarket Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
2 months ago - Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
2 months ago - Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
5 months ago - Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings Provides Corporate Update/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...
6 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
CELZ Twits
Here you can normally see the latest stock twits on CELZ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
